Risk of dementia or cognitive impairment in COPD patients: A meta-analysis of cohort studies
Jun Wang, Xuanlin Li, Siyuan Lei, Dong Zhang, Shujuan Zhang, Hailong Zhang, Jiansheng Li
Abstract
Purpose A meta-analysis of cohort studies was performed to evaluate the association between COPD and the risk of dementia or cognitive impairment. Methods Cohort studies that evaluated the association between COPD and the risk of dementia or cognitive impairment were identified by a systematic search of PubMed, Embase, Web of Science, and Cochrane Library databases. The search time frame was from database establishment to April 12, 2022, with two reviewers independently screening the literature and extracting data. The Newcastle-Ottawa Quality Assessment Scale (NOS) was used to conduct the quality evaluation. Then, a meta-analysis was performed using Stata 15.1 software. Results Six cohort studies including 428,030 participants were included. The overall quality of the included studies was high, with an average NOS score of over 7. Meta-analysis showed that compared to those without COPD at baseline, patients with COPD were associated with a significant increased risk of dementia ( RR = 1.24, 95% CI = 1.03 ~ 1.50, I 2 = 96.6%, z = 2.25, p = 0.024) and cognitive impairment ( RR = 1.30, 95% CI = 1.13 ~ 1.49, I 2 = 50.1%, z = 3.72, p < 0.001). Subgroup analysis suggested no significant difference in the risk of dementia among COPD patients of different genders. Nevertheless, in terms of age, the risk of dementia varied among COPD patients of different ages, which was most distinguished in patients younger than 65 years. Conclusion COPD patients have a higher risk of developing dementia or cognitive impairment compared to those without COPD, and this risk is not affected by gender but seems to be associated with age. Systematic review registration https://www.crd.york.ac.uk/prospero/ , identifier CRD42022325832.